NCT07240506

Brief Summary

This study aimed to examine the acute effects of caffeine intake through caffeinated chewing gum on the vertical jump performance of professional female volleyball players. Ten athletes from the Turkish Women's Volleyball First League voluntarily participated in this single-blind, placebo-controlled, randomized crossover study. Each athlete completed two test sessions: one with caffeinated gum containing 200 mg of caffeine and one with a caffeine-free placebo gum. After chewing the gum for 5 minutes, participants performed three types of vertical jump tests: squat jump, countermovement jump, and block jump. The results showed that caffeinated gum significantly improved countermovement jump height compared with the placebo, while no significant differences were observed for squat or block jumps. The findings suggest that caffeine in gum form may enhance explosive performance in sports requiring rapid power output, such as volleyball.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2025

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 21, 2025

Completed
Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

10 days

First QC Date

November 16, 2025

Last Update Submit

November 21, 2025

Conditions

Keywords

CaffeineCaffeinated GumFemale AthletesJump PerformanceSports Nutrition

Outcome Measures

Primary Outcomes (1)

  • Countermovement Jump Height

    Change in countermovement jump (CMJ) height measured using a Chronojump contact mat following caffeine or placebo gum ingestion.

    Within 15 minutes after gum administration.

Secondary Outcomes (2)

  • Squat Jump Height

    Within 15 minutes after gum administration.

  • Block Jump Height

    Within 15 minutes after gum administration.

Study Arms (2)

Caffeinated Gum (CAF)

EXPERIMENTAL

Participants chewed two pieces of caffeinated chewing gum containing a total of 200 mg caffeine (2 × 100 mg). After chewing for 5 minutes, they performed squat jump, countermovement jump, and block jump tests.

Dietary Supplement: Caffeinated chewing gum

Placebo Gum (PLA)

PLACEBO COMPARATOR

Participants chewed two pieces of placebo chewing gum identical in appearance and flavor but containing no caffeine. After chewing for 5 minutes, they performed the same vertical jump tests as in the caffeinated condition.

Dietary Supplement: Placebo chewing gum

Interventions

Caffeinated chewing gumDIETARY_SUPPLEMENT

Two pieces of caffeinated chewing gum providing 200 mg total caffeine; administered 15 minutes before performance testing.

Caffeinated Gum (CAF)
Placebo chewing gumDIETARY_SUPPLEMENT

Two pieces of placebo chewing gum identical in appearance and flavor to the caffeinated gum but containing no caffeine; administered 15 minutes before performance testing.

Placebo Gum (PLA)

Eligibility Criteria

Age18 Years - 33 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly self-identified female athletes were eligible to participate in this study. Participants were professional volleyball players competing in the Turkish Women's Volleyball First League.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Self-identified female athletes aged 18-33 years Professional volleyball players actively competing in the Turkish Women's Volleyball First League Minimum of 3 years of competitive volleyball experience Healthy individuals without any diagnosed medical conditions Willing to abstain from caffeine-containing products for at least 24 hours before each testing session Voluntarily agreed to participate and provided written informed consent

You may not qualify if:

  • Known cardiovascular, metabolic, or neurological disorders Current use of medications or supplements affecting physical performance or caffeine metabolism Pregnancy or breastfeeding History of caffeine sensitivity, intolerance, or allergy Failure to comply with pre-test instructions (e.g., caffeine restriction, rest period) Musculoskeletal injuries preventing full jump performance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yeşilyurt Sports Club - Women's Volleyball Team Training Facility

Istanbul, Bakırköy, 34149, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 16, 2025

First Posted

November 21, 2025

Study Start

February 10, 2025

Primary Completion

February 20, 2025

Study Completion

May 1, 2025

Last Updated

November 28, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared because the dataset contains identifiable information related to a small group of professional athletes. Only summarized results are available within the published manuscript and supplementary materials upon reasonable request.

Locations